Development and in-vitro evaluation of sustained release Poloxamer 407 (P407) gel formulations of ceftiofur

被引:166
作者
Zhang, L
Parsons, DL
Navarre, C
Kompella, UB
机构
[1] Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA
[2] Hoffman La Roche, Nutley, NJ USA
[3] Auburn Univ, Dept Pharmacol Sci, Auburn, AL 36849 USA
[4] Auburn Univ, Large Anim Clin, Auburn, AL 36849 USA
关键词
sustained release; Poloxamer; 407; ceftiofur; in-vitro release;
D O I
10.1016/S0168-3659(02)00273-0
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The objective of this study was to develop sustained release Poloxamer 407 (P407) gel formulations of ceftiofur for treating foot infections in cattle. The formulations contained 25-35% (w/v) P407 alone or with polyvinyl pyrrolidone (PVP), carboxy methylcellulose (CMC), or hydroxylpropyl methylcellulose (HPMC) as an additive. The in-vitro release profiles of ceftiofur from the P407 formulations and the gel dissolution profiles were obtained simultaneously. Ceftiofur release followed zero order kinetics and correlated well with the weight percentage of P407 dissolved, indicating that the overall rate of release of ceftiofur is controlled by dissolution of the P407. An increase in P407 content from 25 to 35% resulted in a decrease in the rate of ceftiofur release. However, it appears that other factors may have also affected the drug release rate, Inclusion of PVP, CMC, and HPMC in the gel decreased the rate of release of ceftiofur to some extent. A decrease in the temperatures of the release medium decreased the release rate of ceftiofur, but not the rate of gel dissolution. The pH of the release medium showed a very slight effect on the release of ceftiofur and did not affect gel dissolution due to the non-ionic nature of P407. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:73 / 81
页数:9
相关论文
共 16 条
[1]   Controlled-release delivery system for the alpha-MSH analog melanotan-I using poloxamer 407 [J].
Bhardwaj, R ;
Blanchard, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (09) :915-919
[2]  
Brown S. A., 1991, Acta Veterinaria Scandinavica, P95
[3]  
CHENCHOW PC, 1981, INT J PHARM, V8, P89
[4]   Pharmacokinetics of ceftiofur and metabolites after single intravenous and intramuscular administration and multiple intramuscular administrations of ceftiofur sodium to dairy goats [J].
Courtin, F ;
Craigmill, AL ;
Wetzlich, SE ;
Gustafson, CR ;
Arndt, TS .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1997, 20 (05) :368-373
[5]   DRUG RELEASE FROM PLURONIC F-127 GELS [J].
GILBERT, JC ;
HADGRAFT, J ;
BYE, A ;
BROOKES, LG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 32 (2-3) :223-228
[6]   BIODEGRADABLE POLYMERS FOR PROTEIN AND PEPTIDE DRUG-DELIVERY [J].
GOMBOTZ, WR ;
PETTIT, DK .
BIOCONJUGATE CHEMISTRY, 1995, 6 (04) :332-351
[7]   GENTAMICIN-COLLAGEN SPONGE FOR LOCAL APPLICATIONS - 10 CASES OF CHRONIC OSTEOMYELITIS FOLLOWED FOR 1 YEAR [J].
IPSEN, T ;
JORGENSEN, PS ;
DAMHOLT, V ;
TORHOLM, C .
ACTA ORTHOPAEDICA SCANDINAVICA, 1991, 62 (06) :592-594
[8]  
JURGENSENEIDE G, 1967, ACTA PHARM SUEC, V4, P185
[9]  
MACKEY D, 1982, CLIN ORTHOP RELAT R, P263
[10]   Experimental investigation and mathematical modeling of Pluronic® F127 gel dissolution:: drug release in stirred systems [J].
Moore, T ;
Croy, S ;
Mallapragada, S ;
Pandit, N .
JOURNAL OF CONTROLLED RELEASE, 2000, 67 (2-3) :191-202